Malfertheiner P, Megraud F, OMorain C, Gisbert JP, Kuipers EJ, Axon A, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar E, Agreus L, Andersen LP, Coelho L, Delchier JC, Di Mario F, Dinis-Ribeiro M, Fischbach W, Flahou B, Fock KM, Gasbarrini G, Gensini G, Goh KL, Herrero R, Kupcinskas L, Lanas A, Leja M, Machado JC, Mahachai V, Milosavljevic T, Niv Y, Ristimaki A, Tepes B, Vaira D, Vieth M, You W (2017) Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report
injection of 3% thioglycollate
doi: 10.1038/s41598-018-24879-x 8 SchoepTDFulurijaAGoodFLuWHimbeckRPSchwanCet al
Intravenous glutathione carries higher risksincluding infection, vein irritation, and drug interactionsand should only be administered under medical supervision with clear clinical justification